Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Tryptamine Therapeutics ( (AU:TYP) ) is now available.
Tryptamine Therapeutics Limited has requested a trading halt on its securities as it plans a capital raising initiative. This move is expected to impact the company’s financial strategy and market positioning, with the halt in place until the announcement of the capital raising or the resumption of trading on November 5, 2025.
More about Tryptamine Therapeutics
Tryptamine Therapeutics Limited operates in the biotechnology industry, focusing on therapeutic solutions. The company is listed on the Australian Securities Exchange under the ticker TYP.
Average Trading Volume: 2,058,706
Technical Sentiment Signal: Buy
Current Market Cap: A$54.72M
See more data about TYP stock on TipRanks’ Stock Analysis page.